DAVID V SMITH Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID V SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID V SMITH. DAVID V SMITH is V.P. & Chief Financial Officer in CHIRON CORP ($CHIR) and V.P.; Chief Financial Officer in CHIRON CORP ($CHIR) and Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Executive Vice President & CFO in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CODEXIS INC ($CDXS).
DAVID V SMITH in FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID V SMITH: Executive Vice President & CFO
Holdings: 138,947 shares
Current Value: $6,305,415
Latest Transaction: Apr 19 2021
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID V SMITH in FIVE PRIME THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, CHIR, CDXS, FPRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 12.47 | 185,000 | 2,306,950 | 0 | |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Sell | D | 38.00 | 138,947 | 5,279,986 | 0 | 138.9 K to 0 (-100.00 %) |
| Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 66,000 | 0 | 138,947 | 72.9 K to 138.9 K (+90.48 %) |
| Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 25.71 | 5,110 | 131,378 | 72,947 | 78.1 K to 72.9 K (-6.55 %) |
| Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | M | 0.00 | 22,000 | 0 | 0 | |
| Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 16.14 | 11,504 | 185,675 | 78,057 | 89.6 K to 78.1 K (-12.84 %) |
| Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Buy | M | 0.00 | 22,000 | 0 | 89,561 | 67.6 K to 89.6 K (+32.56 %) |
| Nov 30 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 18.45 | 6,920 | 127,674 | 67,561 | 74.5 K to 67.6 K (-9.29 %) |
| Nov 30 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 18.45 | 6,920 | 127,674 | 67,561 | 74.5 K to 67.6 K (-9.29 %) |
| Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
| Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 5.25 | 90,000 | 472,500 | 90,000 | |
| Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 15,000 | 0 | 63,389 | 48.4 K to 63.4 K (+31.00 %) |
| Mar 11 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 15,000 | 0 | 48,389 | 33.4 K to 48.4 K (+44.92 %) |
| Nov 27 2019 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 3.77 | 6,611 | 24,923 | 33,389 | 40 K to 33.4 K (-16.53 %) |
| Jun 26 2019 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 0.00 | 44,000 | 0 | 44,000 | |
| Nov 27 2018 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | A | 12.47 | 185,000 | 2,306,950 | 185,000 | |
| Nov 27 2018 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Page: 1